Finance

Beta
Lists
082800:KOSDAQ
Vivozon Pharmaceutical Co Ltd
â‚©4,045.00
+3.06%
(+120.00) 1D
Jun 12, 3:30:10 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 082800...
Open
â‚©3,885
High
â‚©4,305
Low
â‚©3,625
Mkt. cap
245.61B
Avg. vol.
1.49M
Volume
0.00
52-wk high
â‚©8,275
52-wk low
â‚©2,150
EPS
-â‚©654
Shares outstanding
60.72M
No. of employees
307
Open
â‚©3,885
High
â‚©4,305
Low
â‚©3,625
Mkt. cap
245.61B
Avg. vol.
1.49M
Volume
0.00
52-wk high
â‚©8,275
52-wk low
â‚©2,150
EPS
-â‚©654
Shares outstanding
60.72M
No. of employees
307
News stories
From sources across the web
About Vivozon Pharmaceutical Co Ltd
CEO-
Employees307
Founded2002
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
17.80B
6.76B
16.20B
14.11B
Cost of goods sold
8.82B
7.80B
9.56B
8.29B
Cost of revenue
8.82B
7.80B
9.56B
8.29B
Research and development expenses
839.43M
534.26M
755.11M
728.70M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
10.51B
8.21B
8.82B
7.45B
Operating expense
11.71B
9.17B
10.37B
8.84B
Total operating expenses
20.53B
16.96B
19.93B
17.13B
Operating income
-2.73B
-10.20B
-3.73B
-3.02B
Other non operating income
-22.74M
-3.76M
276.32M
-847.05M
EBT including unusual items
-4.22B
-11.58B
-12.73B
-5.55B
EBT excluding unusual items
-4.22B
-11.58B
-6.14B
-5.55B
Income tax expense
-
-
48.61M
-
Effective tax rate
-
-
-0.38%
-
Other operating expenses
-
-
-
-
Net income
-4.22B
-11.64B
-12.79B
-5.56B
Net profit margin
-23.73%
-172.29%
-78.93%
-39.40%
Earnings per share
-
-
-
-
Interest and investment income
38.84M
18.83M
99.82M
40.18M
Interest expense
-511.31M
-551.99M
-629.92M
-740.02M
Net interest expenses
-472.47M
-533.16M
-530.10M
-699.85M
Depreciation and amortization charges
196.02M
202.63M
196.55M
191.40M
EBITDA
-1.70B
-9.17B
-2.44B
-1.75B
Gain or loss from assets sale
-1.92M
-392.79K
91.78M
-1.65M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more